Apr 19, 2021 10:30am EDT Todos Medical Launches Phase 2 Clinical Trial of Its Antiviral 3CL Protease Inhibitor NLC-V-01 (Tollovir) in Hospitalized COVID-19 Patients
Apr 08, 2021 9:27am EDT Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application Covering Diagnosis of Cancer Using Proprietary Artificial Intelligence TBIA Immune Profiling Platform
Apr 01, 2021 7:00am EDT Todos Medical Completes Automation Equipment Installation and Training for Meadowlands Diagnostics
Mar 30, 2021 9:23am EDT Todos Medical Enters Into Distribution Partnership with Osang Healthcare for the GeneFinder Plus™ COVID-19 Plus RealAMP Kit in the United States
Mar 29, 2021 7:20am EDT Todos Medical Completes Automation Equipment Installation and Training for a Laboratory Client in Brooklyn, NY
Mar 23, 2021 8:00am EDT Todos Medical Enters Into Automation and Reagent Supply Agreement with MAJL Diagnostics
Mar 12, 2021 9:39am EST Todos Medical Announces $7.2M in Sales for February 2021, a 38% Month Over Month Increase From Sales of $5.2M in January 2021
Jan 11, 2021 8:30am EST Todos Medical Announces $4.8 Million in Sales for December 2020, a 50% Month Over Month Increase in Sales from November 2020
